Back to top
more

Chemours (CC)

(Delayed Data from NYSE)

$16.13 USD

16.13
2,170,039

-0.21 (-1.29%)

Updated Oct 3, 2025 04:00 PM ET

After-Market: $16.13 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.81%
2Buy17.98%
3Hold9.90%
4Sell5.43%
5Strong Sell2.74%
S&P50011.32%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 6% (231 out of 245)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Chemours (CC) Adds Glyclean D to its Glycolic Acid Portfolio

by Zacks Equity Research

Chemours' (CC) new disinfectant product, Glyclean D, promises to be an environmental-friendly household cleaner.

Zacks Equity Research

Best Growth Stocks to Buy for November 16th

by Zacks Equity Research

TGLS, CC, and DDS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 16, 2021.

Zacks Equity Research

U.S. Steel (X) to Transfer $284M in Pension Plan Obligations

by Zacks Equity Research

U.S. Steel's (X) transaction is another significant step in strengthening the company's balance sheet and further de-risking its pension plan.

Zacks Equity Research

Air Products (APD) to Display Technologies at ADIPEC in UAE

by Zacks Equity Research

Air Products' (APD) purpose is to bring people together to collaborate and innovate solutions to the world's most significant energy and environmental sustainability challenges.

Zacks Equity Research

Here Is Why Bargain Hunters Would Love Fast-paced Mover Chemours (CC)

by Zacks Equity Research

Chemours (CC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Zacks Equity Research

Mosaic (MOS) Announces Revenues and Volumes for October

by Zacks Equity Research

Mosaic (MOS) witnesses an improvement in sales revenues across all the segments in October.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Chemours, Lenovo, Ternium, Earthstone Energy and LendingClub

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Chemours, Lenovo, Ternium, Earthstone Energy and LendingClub

Zacks Equity Research

Chemours (CC) Starts Opteon 1150 Production in its New Plant

by Zacks Equity Research

Chemours (CC) begins production of its Opteon 1150 platform to contribute to low GWP solutions and support environmental sustainability.

Sejuti Banerjea headshot

Inflation Hasn't Hurt Sentiment, but Should You Play It Safe?

by Sejuti Banerjea

A safe strategy with huge potential.

Zacks Equity Research

Best Growth Stocks to Buy for November 11th

by Zacks Equity Research

TGLS, CC, and NMRK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 11, 2021.

Zacks Equity Research

Century Aluminum (CENX) Begins Construction of a New Casthouse

by Zacks Equity Research

Century Aluminum's (CENX) new expansion project will enhance Grundartangi's annual capacity to manufacture primary foundry alloys.

Zacks Equity Research

Kinross' (KGC) Earnings Beat, Revenues Lag Estimates in Q3

by Zacks Equity Research

Kinross' (KGC) Q3 results are impacted by lower gold production and higher costs.

Zacks Equity Research

Best Value Stocks to Buy for November 11th

by Zacks Equity Research

MRBK, CC, TGH, and SGH made it to the Zacks Rank #1 (Strong Buy) value stocks list on November 11, 2021

Zacks Equity Research

New Strong Buy Stocks for November 11th

by Zacks Equity Research

BLDR, FLGT, MRBK, CC, and NMRK have been added to the Zacks Rank #1 (Strong Buy) List on November 11th.

Zacks Equity Research

Is Chemours (CC) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Ashland's (ASH) Earnings and Revenues Lag Estimates in Q4

by Zacks Equity Research

Ashland (ASH) Q4 performance benefits from strong demand in core markers and higher prices, despite headwinds from global supply-chain and logistics disruptions.

Zacks Equity Research

Mosaic (MOS) Declares Secondary Offering Pricing & Share Buyback

by Zacks Equity Research

Mosaic (MOS) agrees to repurchase 25% out of the 34,176,574 shares of common stock that are subject to offering from the underwriter.

Zacks Equity Research

Cabot's (CBT) Q4 Earnings Beat Estimates, Revenues Lag

by Zacks Equity Research

Cabot's (CBT) Q4 results benefit from higher volumes and strong pricing in the Reinforcement Material segment.

Zacks Equity Research

Kirkland Lake Gold (KL) Earnings and Sales Top Estimates in Q3

by Zacks Equity Research

Kirkland Lake Gold's (KL) Q3 results gain from an increase in gold production.

Zacks Equity Research

Scotts Miracle-Gro (SMG) Beats Q4 Earnings & Sales Estimates

by Zacks Equity Research

Scotts Miracle-Gro's (SMG) Q4 results are impacted by lower sales in all the segments.

Zacks Equity Research

Barrick's (GOLD) Earnings Beat Estimates in Q3, Sales Lag

by Zacks Equity Research

Barrick (GOLD) gains from improved performance at Nevada Gold mines in Q3, while results are hurt by lower gold prices.

Zacks Equity Research

Chemours (CC) Earnings and Revenues Surpass Estimates in Q3

by Zacks Equity Research

Chemours (CC) benefits from strengthening pricing across its portfolio and higher volumes on strong demand in Q3.

Zacks Equity Research

Chemours (CC) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Chemours (CC) delivered earnings and revenue surprises of 28.28% and 2.55%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

CF Industries' (CF) Earnings and Sales Miss Estimates in Q3

by Zacks Equity Research

CF Industries' (CF) Q3 earnings are impacted by decreased volumes, due to lower supply availability stemming from reduced production.

Zacks Equity Research

Nutrien's (NTR) Earnings and Sales Surpass Estimates in Q3

by Zacks Equity Research

Nutrien's (NTR) Q3 results benefit from higher sales across all the segments and strong demand for crop inputs.